Back to NBIX
Swedbank AB NBIX Position History
Neurocrine Biosciences, Inc. • Healthcare
Quarters held
5
Latest value
$107M
Q3 2026
Peak value
$109.7M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $82.8M |
| Q4 2025 | $82.8M |
| Q1 2026 | $76.3M |
| Q2 2026 | $109.7M |
| Q3 2026 | $107M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $107M | 754.3K | — | — |
| Q2 2026 | $109.7M | 651.1K | — | — |
| Q1 2026 | $76.3M | 579.4K | — | — |
| Q4 2025 | $82.8M | 584.1K | — | — |
| Q4 2025 | $82.8M | 584.1K | — | — |
Other funds holding NBIX
$1.3B
$1.3B
$1.2B
$1.1B
$997.5M
$967.6M
$941.2M
$917.9M